PMC:7544943 / 158-1801
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 301-308 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T2 | 433-441 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T2 | 4-51 | Disease | denotes | severe acute respiratory syndrome coronavirus 2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T3 | 4-37 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T4 | 53-61 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T5 | 76-94 | Disease | denotes | infectious disease | http://purl.obolibrary.org/obo/MONDO_0005550 |
T6 | 284-292 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T7 | 310-318 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T8 | 339-347 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T9 | 365-373 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T10 | 689-697 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T11 | 929-937 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T12 | 1008-1016 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T13 | 1626-1634 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 68-69 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T2 | 166-167 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T3 | 495-500 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T4 | 716-717 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T5 | 990-998 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | actively |
T6 | 1051-1054 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T7 | 1327-1329 | http://purl.obolibrary.org/obo/CLO_0007622 | denotes | MD |
T8 | 1637-1642 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
22 | 295-300 | Gene | denotes | spike | Gene:43740568 |
23 | 376-380 | Gene | denotes | Mpro | Gene:8673700 |
24 | 1032-1036 | Gene | denotes | Mpro | Gene:8673700 |
25 | 1486-1490 | Gene | denotes | Mpro | Gene:8673700 |
26 | 1274-1278 | Gene | denotes | Mpro | Gene:8673700 |
27 | 921-925 | Gene | denotes | Mpro | Gene:8673700 |
28 | 4-51 | Species | denotes | severe acute respiratory syndrome coronavirus 2 | Tax:2697049 |
29 | 53-63 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
30 | 284-294 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
31 | 310-320 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
32 | 339-349 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
33 | 365-375 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
34 | 689-699 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
35 | 929-939 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
36 | 1008-1018 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
37 | 1626-1636 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
38 | 1042-1050 | Chemical | denotes | Piperine | MESH:C008922 |
39 | 1156-1164 | Chemical | denotes | Piperine | MESH:C008922 |
40 | 1200-1208 | Chemical | denotes | Piperine | MESH:C008922 |
41 | 1247-1255 | Chemical | denotes | Piperine | MESH:C008922 |
42 | 1459-1467 | Chemical | denotes | Piperine | MESH:C008922 |
43 | 76-94 | Disease | denotes | infectious disease | MESH:D003141 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 112-118 | http://purl.obolibrary.org/obo/GO_0040007 | denotes | growth |
T2 | 200-217 | http://purl.obolibrary.org/obo/GO_0019079 | denotes | viral replication |
T3 | 200-217 | http://purl.obolibrary.org/obo/GO_0019058 | denotes | viral replication |
T4 | 236-267 | http://purl.obolibrary.org/obo/GO_1900121 | denotes | inhibiting the receptor-binding |
T5 | 474-487 | http://purl.obolibrary.org/obo/GO_0006351 | denotes | transcription |
T6 | 1446-1455 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | formation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T7 | 0-119 | Sentence | denotes | The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel infectious disease that is in rapid growth. |
T8 | 120-195 | Sentence | denotes | Several trials are going on worldwide to find a solution for this pandemic. |
T9 | 196-382 | Sentence | denotes | The viral replication can be blocked by inhibiting the receptor-binding domain (RBD) of SARS-CoV-2 spike protein (SARS-CoV-2 RBD Spro) and the SARS-CoV-2 main protease (SARS-CoV-2 Mpro). |
T10 | 383-501 | Sentence | denotes | The binding of potential small molecules to these proteins can inhibit the replication and transcription of the virus. |
T11 | 502-604 | Sentence | denotes | The spice molecules that are used in our food have antiviral, antifungal and antimicrobial properties. |
T12 | 605-737 | Sentence | denotes | As spice molecules are consumed in the diet, hence its antiviral properties against SARS-CoV-2 will benefit in a significant manner. |
T13 | 738-940 | Sentence | denotes | Therefore, in this work, the molecular docking of 30 selected spice molecules (screened through ADME property) was performed to identify the potential inhibitors for the RBD Spro and Mpro of SARS-CoV-2. |
T14 | 941-1116 | Sentence | denotes | We have found that though all the molecules bind actively with the SARS-CoV-2 RBD Spro and Mpro, but Piperine has the highest binding affinity among the 30 screened molecules. |
T15 | 1117-1227 | Sentence | denotes | Besides, the comparative study between Piperine and currently used drugs show that Piperine is more effective. |
T16 | 1228-1350 | Sentence | denotes | The interaction of Piperine with RBD Spro and Mpro is further validated by the molecular dynamics (MD) simulation studies. |
T17 | 1351-1491 | Sentence | denotes | The free energy landscape and binding free energy results also, support for the stable complex formation of Piperine with RBD Spro and Mpro. |
T18 | 1492-1643 | Sentence | denotes | We anticipate immediate wet-lab experiments and clinical trials in support of this computational study that might help to inhibit the SARS-CoV-2 virus. |